High-Grade Serous Ovarian Cancer — Trials

High-Grade Serous Ovarian Cancer — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 13
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: University Health Network, Toronto
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01883297	"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	active not recruiting	Phase 1	3	University Health Network, TorontoOTHER	1	Jul 7, 2026	clinicaltrials

Data updated 22 days agoSource updated Jul 7, 2026source: clinicaltrials